Inventor · disambiguated record
Tatiana Zavorotinskaya
Also filed as: ZAVOROTINSKAYA TATIANA
10 granted patents·4 pending applications·72 citations·filing 1999–2025
89Inventor score
Top patents by PatentIndex Score
14 records- 0196US11028120B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·10 cites·30 claims
- 0295US12018043B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·6 cites·33 claims
- 0395US11130778B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Sep 28, 2021·8 cites·30 claims
- 0494US11530236B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·4 cites·25 claims
- 0593US11325938B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·9 cites·20 claims
- 0689US8822497B2PIM kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2008·Granted Sep 2, 2014·10 cites·9 claims
- 0788US11377469B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2018·Granted Jul 5, 2022·5 cites·19 claims
- 0887US12454544B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2024·Granted Oct 28, 2025·0 cites·9 claims
- 0985US11807658B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Nov 7, 2023·1 cites·19 claims
- 1083US2025368677A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1176US2024124512A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1267US2022259253A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1363US6448390B1Stable envelope proteins for retroviral, viral and liposome vectors and use in gene drug therapyUNIV TENNESSEE RES CORP·Filed 1999·Granted Sep 10, 2002·19 cites·13 claims
- 1451US2014249135A1Pim kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tatiana Zavorotinskaya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →